FDA and CDC expand approval of updated Moderna and Pfizer-BioNTech COVID-19 booster vaccines for children Ages 5-17
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On October 12, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 vaccines for children ages 5-17. Under the amended EUA, the Moderna vaccine is authorized for children ages 6 through 17 years of age, and the Pfizer vaccine is authorized for children five to 11 years of age.
Following FDA authorization, the Centers for Disease Control and Prevention (CDC), updated their COVID-19 vaccination recommendations to include the boosters for this younger age group.
Updated COVID-19 boosters add Omicron BA.4 and BA.5 variants to the current vaccine composition, helping to restore protection that has waned since previous vaccination and targeting recent Omicron strains that are more transmissible and immune compromising.
The approval of the updated COVID-19 boosters is a critical next step in the nation’s pandemic recovery efforts. County governments have been on the front lines of our nation’s vaccination efforts and will continue to work to coordinate distribution and administration of vaccines, which provide increased protection against severe COVID-19 disease and mortality.
ADDITIONAL RESOURCES
Resource
The County Role in Vaccines
Related News
HALT Fentanyl Act signed into law
On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.
Public-private partnership creates ‘one-stop shop’ to improve community wellness
The South Philadelphia Community Health and Literacy Center is a “one-stop shop” the city and the children’s hospital created to improve community wellness and make it easier for people to get their needs met.